Lucid Diagnostics (LUCD) Financials: Revenue & Earnings

LUCD price $0.39 -0.05 -11.96%

Ticker
LUCD
Price
$0.39
Change
-0.05 -11.96%
Market cap ?
$73.65M
P/E ?
-0.90
Dividend yield ?
0.00%
Beta ?
1.12
Sector
Healthcare
Industry
Medical - Devices
Stocklytics score
65
Value
59
Quality
40
Growth
96

Stocklytics score rationale: value 59, quality 40, growth 96.

Financials

20182019202020212022202320242025
000500000377000242800043460004706000

Lucid Diagnostics Inc. is a commercial-stage medical technology firm focused on diagnostic solutions. The company's primary objective is to serve patients afflicted with gastroesophageal reflux disease (GERD), commonly referred to as chronic heartburn or acid reflux, especially those at increased risk of developing precancerous esophageal conditions or the particularly aggressive esophageal adenocarcinoma. Their key…

Fair value

LUCD fair value Not meaningful. Price $0.39.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare LUCD

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-11—-0.04—1.63M
2026-08-13-0.06-0.061.47M1.43M
2026-05-14-0.07-0.051.26M1.38M
2026-03-25-0.10-0.071.50M1.36M
2025-11-12-0.10-0.061.21M1.39M
2025-08-13-0.10-0.091.16M1.71M
2025-05-14-0.16-0.09828.00K1.54M
2025-03-24-0.19-0.151.20M1.25M
2024-11-13-0.20-0.161.17M1.42M
2024-08-12-0.20-0.22976.00K1.48M
2024-05-13-0.40-0.271.01M1.05M
2024-03-26-0.25-0.261.05M1.04M
2023-11-13-0.24-0.27783.00K1.11M
2023-08-14-0.23-0.32159.00K620.00K
2023-05-15-0.24-0.35446.00K238.78K
2023-03-14-0.290.38112.00K620.00K
2022-11-14-0.28-0.4076.00K431.38K
2022-08-15-0.41-0.33—630.41K
2022-05-11-0.23-0.30189.00K462.86K
2022-03-28-0.32-0.20300.00K390.88K
2021-11-23-0.49-0.32200.00K200.00K
2021-10-14-0.17———
2021-03-31-0.10———
2020-12-31-0.07———
2020-09-30-0.05———
2020-06-30-0.09———
2020-03-31-0.16———
2018-12-31-0.08———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-05-20Matheis DennisBuy245.00K$1.00245.27K
2026-03-23Lee Victoria Tou-hoOther100.00K$1.25125.00K
2026-03-23Lee Victoria Tou-hoOther0——
2026-02-20Aklog LishanBuy2.17M——
2026-02-20Matheis DennisBuy123.00K——
2026-02-20White DebraBuy123.00K——
2026-02-20Sparks Ronald MBuy123.00K——
2026-02-20SOKOLOV JACQUE JBuy123.00K——
2026-02-20PALUMBO JOHN RBuy123.00K——
2026-02-20Lapidus StanleyBuy123.00K——
2026-02-20Cox James LBuy123.00K——
2026-02-20MCGRATH DENNIS MBuy470.00K——
2026-02-20O'Neil ShaunBuy620.00K——
2026-02-20Gordon Michael AdamBuy300.00K——
2025-10-06PALUMBO JOHN RBuy215.00K$1.03221.45K
2025-09-22PALUMBO JOHN ROther0——
2025-08-20Matheis DennisBuy100.00K$1.02101.84K
2025-05-22Matheis DennisBuy33.22K$1.3243.79K
2025-05-22Matheis DennisBuy33.22K$1.3243.79K
2025-05-21Matheis DennisBuy129.68K$1.32171.52K
2025-05-21Matheis DennisBuy129.68K$1.32171.52K
2025-05-20Matheis DennisBuy187.10K$1.29242.29K
2025-05-20Matheis DennisBuy187.10K$1.29242.29K
2025-02-20O'Neil ShaunBuy300.00K——
2025-02-20Aklog LishanBuy300.00K——
2025-02-20SOKOLOV JACQUE JBuy112.80K——
2025-02-20Lapidus StanleyBuy112.80K——
2025-02-20Matheis DennisBuy112.80K——
2025-02-20Cox James LBuy112.80K——
2025-02-20MCGRATH DENNIS MBuy300.00K——
2025-02-20Gordon Michael AdamBuy300.00K——
2025-02-20White DebraBuy112.80K——
2025-02-20Sparks Ronald MBuy112.80K——
2024-05-08Matheis DennisBuy241.50K$1.03248.75K
2024-05-07Gordon Michael AdamBuy400.00K——
2024-05-07O'Neil ShaunBuy400.00K——
2024-05-07MCGRATH DENNIS MBuy400.00K——
2024-05-07Aklog LishanBuy400.00K——
2024-05-06Matheis DennisSell0——
2024-02-22White DebraBuy150.00K$1.23184.50K
2024-02-22Sparks Ronald MBuy150.00K$1.23184.50K
2024-02-22Lapidus StanleyBuy150.00K$1.23184.50K
2024-02-22Cox James LBuy150.00K$1.23184.50K
2024-02-22SOKOLOV JACQUE JBuy150.00K$1.23184.50K
2024-02-15PAVmed Inc.Sell3.33M——
2024-01-26PAVmed Inc.Buy3.33M$1.404.68M
2023-09-26Lapidus StanleySell10.00K$1.4714.74K
2023-09-26Lapidus StanleySell10.00K$1.4314.30K
2023-09-26Lapidus StanleySell9.75K$1.4514.13K
2023-09-25Lapidus StanleySell200$1.43286
2023-09-21Lapidus StanleySell100$1.44144
2023-09-20Lapidus StanleySell3.40K$1.454.94K
2023-09-20Lapidus StanleySell412$1.44593
2023-01-31Sparks Ronald MBuy175.00K$1.31229.25K
2023-01-31White DebraBuy175.00K$1.31229.25K
2023-01-31SOKOLOV JACQUE JBuy175.00K$1.31229.25K
2023-01-31Lapidus StanleyBuy175.00K$1.31229.25K
2023-01-31Cox James LBuy175.00K$1.31229.25K
2022-11-30PAVmed Inc.Buy1.48M$1.842.72M
2022-11-30PAVmed Inc.Buy331.21K$1.66550.01K
2022-11-30PAVmed Inc.Buy221.95K$2.48550.00K
2022-11-30PAVmed Inc.Buy197.66K$2.78550.00K
2022-11-30PAVmed Inc.Buy1.15M$1.842.11M
2022-11-30PAVmed Inc.Buy1.48M$1.842.72M
2022-11-30PAVmed Inc.Buy331.21K$1.66550.01K
2022-11-30PAVmed Inc.Buy221.95K$2.48550.00K
2022-11-30PAVmed Inc.Buy197.66K$2.78550.00K
2022-11-30PAVmed Inc.Buy1.15M$1.842.11M
2022-09-20Lapidus StanleySell17.00K$1.7129.01K
2022-09-20Lapidus StanleySell16.86K$1.7028.67K
2022-08-02White DebraBuy80.00K——
2022-08-01White DebraOther0——
2022-06-07Gordon Michael AdamBuy200.00K——
2022-05-31Gordon Michael AdamOther0——
2022-03-18O'Neil ShaunSell0——
2022-03-18O'Neil ShaunSell50.00K$3.95197.50K
2022-02-18SOKOLOV JACQUE JBuy59.00K$3.95233.05K
2022-02-18Angagaw AsterBuy59.00K$3.95233.05K
2022-02-18Lapidus StanleyBuy59.00K$3.95233.05K
2022-02-18Cox James LBuy59.00K$3.95233.05K
2022-02-18Sparks Ronald MBuy59.00K$3.95233.05K
2022-02-18MCGRATH DENNIS MBuy50.00K$3.95197.50K
2022-02-18Aklog LishanBuy75.00K$3.95296.25K
2022-01-07MCGRATH DENNIS MBuy60.00K——
2022-01-07Aklog LishanBuy60.00K——
2021-10-18Sparks Ronald MBuy84.66K——
2021-10-18PAVmed Inc.Buy571.43K$14.008.00M
2021-10-13Cox James LSell0——
2021-10-13Sparks Ronald MOther0——
2021-10-13Angagaw AsterSell0——
2021-10-13Lapidus StanleySell0——
2021-10-13Wurtman David FSell705.50K$0.71500.90K
2021-10-13SOKOLOV JACQUE JSell0——
2021-10-13MCGRATH DENNIS MSell0——
2021-10-13Aklog LishanSell0——
2021-10-13PAVmed Inc.Sell0——
2021-10-13PAVmed Inc.Other0——
2011-12-27SHEA WILLIAM JSell0——
2011-12-27SHEA WILLIAM JSell200.00K$6.581.32M
2011-12-27SHEA WILLIAM JSell0$9.220

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 118, holders +15 vs prior quarter. Ownership 33.71%.

HolderSharesChangeChange %Value
ALYESKA INVESTMENT GROUP, L.P.8.86M8.86MNew9.48M
BLACKROCK, INC.8.37M3.73M+80.52%8.96M
VANGUARD CAPITAL MANAGEMENT LLC6.56M2.40M+57.80%7.02M
TWO SEAS CAPITAL LP6.00M3.00M+100.00%6.42M
MASTERS CAPITAL MANAGEMENT LLC4.00M00.00%4.28M
ABERDEEN GROUP PLC3.82M178.72K+4.90%4.09M
GEODE CAPITAL MANAGEMENT, LLC3.79M1.54M+68.79%4.06M
STATE STREET CORP2.44M882.76K+56.78%2.61M
FIRST MANHATTAN CO. LLC.2.19M1.87M+576.63%2.34M
WELLS FARGO & COMPANY/MN2.07M792.66K+62.20%2.21M
RUSSELL INVESTMENTS GROUP, LTD.1.65M68.18K+4.31%1.77M
NORTHERN TRUST CORP1.22M549.29K+81.91%1.31M
PERKINS CAPITAL MANAGEMENT INC1.12M-1.00K-0.09%1.20M
VANGUARD FIDUCIARY TRUST CO1.07M444.55K+71.29%1.14M
VANGUARD PORTFOLIO MANAGEMENT LLC1.02M493.49K+93.33%1.09M
UBS GROUP AG845.31K399.83K+89.75%904.49K
AQR CAPITAL MANAGEMENT LLC723.20K488.43K+208.05%773.82K
VERITION FUND MANAGEMENT LLC103.70K103.70KNew693.75K
RAYMOND JAMES FINANCIAL INC577.38K52.45K+9.99%617.80K
LIDO ADVISORS, LLC446.74K63.66K+16.62%478.01K
CHARLES SCHWAB INVESTMENT MANAGEMENT INC325.31K127.89K+64.78%348.08K
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.325.31K325.31KNew348.08K
XML FINANCIAL, LLC323.19K100.00K+44.80%345.82K
BANK OF NEW YORK MELLON CORP301.70K95.40K+46.24%322.82K
BANK OF MONTREAL /CAN/289.94K4.70K+1.65%310.23K

Earnings and financials

Lucid Diagnostics Inc. (LUCD) trades at $0.39, with a market cap of $73.65M and a trailing P/E of -0.90. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

20182019202020212022202320242025
000500000377000242800043460004706000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Lucid Diagnostics (LUCD) Financials: Revenue & Earnings

LUCD$0.39-0.05 -11.96%

$73.65M

Market Cap

-0.90

P/E

—

Forward P/E

65

Score

Price History